Acylphloroglucinol derivatives from Hypericum prolificum

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Organic Chemistry

Background:

• Hypericum prolificum L. is a plant species with potential medicinal properties.
• Acylphloroglucinol derivatives are a class of natural products known for diverse biological activities.

Purpose of the Study:

• To isolate and characterize new acylphloroglucinol derivatives from Hypericum prolificum L.
• To evaluate the in vitro cytotoxic activity of isolated compounds against various human cancer cell lines.

Main Methods:

• Isolation of compounds using hexane extraction.
• Structure elucidation utilizing 2D Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) data.
• In vitro cell proliferation inhibition assays against human breast, lung, CNS, stomach, and colon cancer cell lines.

Main Results:

• Three new acylphloroglucinol derivatives, prolificin A (1), prolifenone A (2), and prolifenone B (3), were successfully isolated and identified.
• Prolificin A exhibited significant growth inhibition across all tested cancer cell lines, with IC50 values ranging from 23 to 36 microM.
• Prolifenones A and B showed no significant inhibitory activity at the tested concentrations.

Conclusions:

• Hypericum prolificum L. is a source of novel acylphloroglucinol derivatives with potential anticancer properties.
• Prolificin A represents a promising lead compound for further investigation in cancer therapy.
• The structural variations in prolifenones A and B may contribute to their lack of observed cytotoxic activity.